Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

NCT00014287 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: gemcitabine hydrochloride

Sponsor

University of Pittsburgh

Collaborators

[object Object]